Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | DBPR728 |
Trade Name | |
Synonyms | |
Drug Descriptions |
DBPR728 is a prodrug inhibitor of Aurora Kinase A (AURKA), which reduces Myc expression, and potentially induces tumor cell apoptosis and inhibits tumor growth (PMID: 38592383). |
DrugClasses | Aurka Inhibitors 27 |
CAS Registry Number | 2702965-64-6 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
DBPR728 | DBPR728 | 0 | 0 |
DBPR728 + Everolimus | DBPR728 Everolimus | 0 | 0 |